| Mineralys Therapeutics, Inc. | 1.32M | US$33.2M | 4.7% |
| Alnylam Pharmaceuticals, Inc. | 121K | US$29.8M | 4.2% |
| Cytokinetics, Incorporated | 362K | US$23.9M | 3.4% |
| iShares Semiconductor ETF | 37,000 | US$21M | 3.0% |
| BridgeBio Pharma, Inc. | 312K | US$20.5M | 2.9% |
| Syndax Pharmaceuticals, Inc. | 1.01M | US$18.9M | 2.7% |
| BioMarin Pharmaceutical Inc. | 293K | US$17.6M | 2.5% |
| Biogen Inc. | 75,763 | US$17.1M | 2.4% |
| Cogent Biosciences, Inc. | 502K | US$16.1M | 2.3% |
| Madrigal Pharmaceuticals, Inc. | 25,795 | US$13M | 1.8% |
| Meta Platforms, Inc. | 16,200 | US$11.7M | 1.7% |
| Sanofi SA | 270K | US$11.1M | 1.6% |
| Maze Therapeutics, Inc. | 366K | US$9.96M | 1.4% |
| Eli Lilly and Company | 8,040 | US$9.3M | 1.3% |
| KLA Corporation | 45,220 | US$8.81M | 1.2% |
| Lam Research Corporation | 25,900 | US$8.51M | 1.2% |
| Pfizer, Inc. | 286K | US$8.16M | 1.2% |
| IDEAYA Biosciences, Inc. | 211K | US$8.12M | 1.1% |
| Rhythm Pharmaceuticals, Inc. | 80,400 | US$7.66M | 1.1% |
| Johnson & Johnson | 28,831 | US$7.63M | 1.1% |
| Tango Therapeutics, Inc. | 304K | US$7.59M | 1.1% |
| Disc Medicine, Inc. | 115K | US$7.51M | 1.1% |
| Vor Biopharma Inc. | 383K | US$7.32M | 1.0% |
| Applied Materials, Inc. | 14,300 | US$7.31M | 1.0% |
| Abivax SA | 73,716 | US$7.3M | 1.0% |
| Merck & Company, Inc. | 48,600 | US$7.06M | 1.00% |
| Nuvectis Pharma, Inc. | 323K | US$6.83M | 0.97% |
| Novartis AG | 45,000 | US$6.41M | 0.91% |
| AbbVie Inc. | 22,256 | US$5.82M | 0.82% |
| First Tracks Biotherapeutics, Inc. | 160K | US$5.68M | 0.80% |
| Trevi Therapeutics, Inc. | 385K | US$5.52M | 0.78% |
| Satellos Bioscience Inc | 639K | US$5.43M | 0.77% |
| Annexon, Inc. | 1.22M | US$5.17M | 0.73% |
| Ultragenyx Pharmaceutical Inc. | 339K | US$5.09M | 0.72% |
| Climb Bio, Inc. | 417K | US$4.78M | 0.68% |
| Cybin, Inc. | 388K | US$4.77M | 0.67% |
| ORIC Pharmaceuticals, Inc. | 349K | US$4.71M | 0.67% |
| Revolution Medicines, Inc. | 22,400 | US$4.6M | 0.65% |
| Novo Nordisk A/S Class B | 121K | US$4.57M | 0.65% |
| Enliven Therapeutics, Inc. | 99,765 | US$4.57M | 0.65% |
| Tenax Therapeutics, Inc. | 2.32M | US$4.38M | 0.62% |
| Tectonic Therapeutic, Inc. | 187K | US$4.37M | 0.62% |
| GSK plc | 90,000 | US$4.34M | 0.61% |
| Relay Therapeutics, Inc. | 234K | US$4.22M | 0.60% |
| Savara, Inc. | 803K | US$4.14M | 0.59% |
| Crescent Biopharma, Inc. | 280K | US$4.08M | 0.58% |
| ACADIA Pharmaceuticals Inc. | 202K | US$4.07M | 0.58% |
| Ovid Therapeutics Inc. | 1.6M | US$3.98M | 0.56% |
| Adlai Nortye Group Ltd. | 236K | US$3.77M | 0.53% |
| Harmony Biosciences Holdings, Inc. | 95,763 | US$3.76M | 0.53% |
| Alpha Cognition Inc. | 416K | US$3.74M | 0.53% |
| Q32 Bio Inc. | 449K | US$3.71M | 0.52% |
| Immix Biopharma, Inc. | 356K | US$3.7M | 0.52% |
| Avalo Therapeutics, Inc. | 235K | US$3.6M | 0.51% |
| Dyne Therapeutics, Inc. | 223K | US$3.59M | 0.51% |
| Eledon Pharmaceuticals, Inc. | 1.39M | US$3.52M | 0.50% |
| Scholar Rock Holding Corporation | 72,265 | US$3.49M | 0.49% |
| Corvus Pharmaceuticals, Inc. | 298K | US$3.43M | 0.49% |
| Rapport Therapeutics, Inc. | 100K | US$3.36M | 0.47% |
| Palisade Bio, Inc. | 2.46M | US$3.33M | 0.47% |
| Larimar Therapeutics, Inc. | 1.04M | US$3.31M | 0.47% |
| Prelude Therapeutics Incorporated | 845K | US$3.3M | 0.47% |
| Evommune, Inc. | 391K | US$3.23M | 0.46% |
| Latigo Biotherapeutics, Inc. | 192K | US$3.21M | 0.45% |
| Applied Optoelectronics, Inc. | 32,210 | US$3.2M | 0.45% |
| Contineum Therapeutics, Inc. | 221K | US$2.97M | 0.42% |
| Celldex Therapeutics, Inc. | 91,096 | US$2.95M | 0.42% |
| Kura Oncology, Inc. | 268K | US$2.87M | 0.41% |
| ProMIS Neurosciences Inc. | 255K | US$2.76M | 0.39% |
| Amgen Inc. | 6,000 | US$2.53M | 0.36% |
| Cabaletta Bio, Inc. | 1.26M | US$2.43M | 0.34% |
| BridgeBio Oncology Therapeutics, Inc. | 464K | US$1.9M | 0.27% |
| Upstream Bio, Inc. | 326K | US$1.72M | 0.24% |
| Pyxis Oncology, Inc. | 689K | US$1.61M | 0.23% |
| Erasca, Inc. | 109K | US$1.6M | 0.23% |
| Jade Biosciences, Inc. | 106K | US$1.48M | 0.21% |
| Inhibikase Therapeutics, Inc. | 688K | US$1.41M | 0.20% |
| BioAge Labs, Inc. | 183K | US$1.29M | 0.18% |
| Taysha Gene Therapies, Inc. | 250K | US$1.22M | 0.17% |
| Intellia Therapeutics, Inc. | 90,250 | US$1.09M | 0.15% |
| Quoin Pharmaceuticals. Ltd | 236K | US$1.08M | 0.15% |
| Surrozen, Inc. | 18,821 | US$606K | 0.09% |
| Werewolf Therapeutics, Inc. | 627K | US$578K | 0.08% |
| Voyager Therapeutics, Inc. | 215K | US$575K | 0.08% |
| Organogenesis Holdings Inc. | 330K | US$452K | 0.06% |
| CytomX Therapeutics, Inc. | 125K | US$341K | 0.05% |
| Traws Pharma, Inc. | 398K | US$237K | 0.03% |
| Aprea Therapeutics, Inc. | 270K | US$203K | 0.03% |
| Skye Bioscience, Inc. | 87,264 | US$140K | 0.02% |
| Ormat Technologies, Inc. | 0 | US$0 | 0.00% |
| Shattuck Labs, Inc. | 0 | US$0 | 0.00% |
| Talen Energy Corporation | 0 | US$0 | 0.00% |
| Teva Pharmaceutical Industries Limited | 0 | US$0 | 0.00% |
| Verastem, Inc. | 0 | US$0 | 0.00% |
| Vistra Corp. | 0 | US$0 | 0.00% |
| Xenon Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Zenas BioPharma, Inc. | 0 | US$0 | 0.00% |
| BioCryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Biohaven Ltd. | 0 | US$0 | 0.00% |
| Constellation Energy Corporation | 0 | US$0 | 0.00% |